Bill Gates Vaccine Feature photo
Pandemic Profiteers

Poor Nations Left Reeling After Bill Gates Advised Oxford to Ditch Open Source COVID Vaccine

Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford’s private partner AstraZeneca, have prioritized those who can pay the most.

Sign Up For The Best Of MintPress, Delivered To Your Daily Inbox.

Sign up for our daily digest.